Faster and Stronger: How RNA Will Advance Precision Medicine and Accessibility

4:15 PM - 5:15 PM (PDT), Wednesday, June 15, 2022

 The power of RNA has become more evident during the COVID-19 pandemic. However, stakeholders are looking closely into how RNA can be leveraged and targeted to treat a multitude of diseases beyond infectious diseases. Join the panel of RNA experts as they discuss how the next generation of therapies using RNA-based technologies and methods to identify novel RNA targets will transform the industry by improving precision medicine and increasing patient accessibility.


 


 

Moderator
photo
Senior healthcare reporter
STAT
Speakers
photo
Co-Founder & CEO
Strand Therapeutics
photo
Investor
Mubadala Capital- Ventures
photo
CEO & Scientific Co-Founder
HAYA Therapeutics
photo
Global Head, NIBR Biologics
Novartis